ArticleNature communications2018

Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target.

Emilio Yángüez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.